SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,503.87 -105.21
(-0.99%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

610.0166926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

24.91

29563.89

EPS(TTM)

Face Value()

Div & Yield %

72.04

Back

golden universal limited

Capital India Finance reports consolidated net loss of Rs 2.92 crore in the December 2025 quarter

Feb 13,2026

Net loss of Capital India Finance reported to Rs 2.92 crore in the quarter ended December 2025 as against net profit of Rs 0.69 crore during the previous quarter ended December 2024. Sales rose 8.71% to Rs 145.96 crore in the quarter ended December 2025 as against Rs 134.26 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	145.96	134.26	9
OPM %	15.67	18.38	-
PBDT	1.68	6.41	-74
PBT	-5.97	-1.62	-269
NP	-2.92	0.69	PL

79,273.33 753.03 ( 0.96%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,503.87 -105.21 (-0.99%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)